TMEM115 is an integral membrane protein of the Golgi complex involved in retrograde transport

Journal of Cell Science

Volumn 127, Issue 13, 2014, Pages 2825-2839

  Ong, Yan Shan ^a   Tran, Ton Hoai Thi ^a   Gounkov, Natalia V ^a   Hong, Wanjin ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

COG complex; Golgi complex; Retrograde transport; TMEM115

Indexed keywords

AGGLUTININ; BETA COP PROTEIN; BREFELDIN A; COAT PROTEIN COMPLEX I; CONSERVED OLIGOMERIC GOLGI 3 COMPLEX PROTEIN; DIMER; ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT PROTEIN 53; GOLGI A4 PROTEIN; GOLGIN A5 PROTEIN; HELIX POMATIA AGGLUTININ; LECTIN; MEMBRANE PROTEIN; OLIGOMER; PEANUT AGGLUTININ; PROTEIN; TMEM 115 PROTEIN; UNCLASSIFIED DRUG; PL6 PROTEIN, HUMAN; PROTEIN BINDING; VESICULAR TRANSPORT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHROMOSOME; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME GLYCOSYLATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GOLGI COMPLEX; HELIX POMATIA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; HELA CELL LINE; METABOLISM; MOUSE; PROTEIN TRANSPORT;

ANIMALS; GOLGI APPARATUS; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICE; PROTEIN BINDING; PROTEIN TRANSPORT; VESICULAR TRANSPORT PROTEINS;

EID: 84903753343     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.136754     Document Type: Article

References (85)

1. Bard, F., Mazelin, L., Péchoux-Longin, C., Malhotra, V. and Jurdic, P. (2003). Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J. Biol. Chem. 278, 46601-46606.
2. Bascom, R. A., Srinivasan, S. and Nussbaum, R. L. (1999). Identification and characterization of golgin-84, a novel Golgi integral membrane protein with a cytoplasmic coiled-coil domain. J. Biol. Chem. 274, 2953-2962.
3. Bianchi, P., Fermo, E., Vercellati, C., Boschetti, C., Barcellini, W., Iurlo, A., Marcello, A. P., Righetti, P. G. and Zanella, A. (2009). Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum. Mutat. 30, 1292-1298.
4. Brockhausen, I. (2006). Mucin-type O-glycans in human colon and breast cancer:glycodynamics and functions. EMBO Rep. 7, 599-604.
5. Campadelli, G., Brandimarti, R., Di Lazzaro, C., Ward, P. L., Roizman, B. and Torrisi, M. R. (1993). Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 90, 2798-2802.
6. Cancino, J. and Luini, A. (2013). Signaling circuits on the Golgi complex. Traffic 14, 121-134.
7. Chia, P. Z. and Gleeson, P. A. (2011). The regulation of endosome-to-Golgi retrograde transport by tethers and scaffolds. Traffic 12, 939-947.
8. Colley, K. J. (1997). Golgi localization of glycosyltransferases: more questions than answers. Glycobiology 7, 1-13.
9. de Albuquerque Garcia Redondo, P., Nakamura, C. V., de Souza, W. and Morgado-Díaz, J. A. (2004). Differential expression of sialic acid and Nacetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J. Histochem. Cytochem. 52, 629-640.
10. Diaz, R. and Stahl, P. D. (1989). Digitonin permeabilization procedures for the study of endosome acidification and function. Methods Cell Biol. 31, 25-43.
11. Eckhardt, M., Gotza, B. and Gerardy-Schahn, R. (1999). Membrane topology of the mammalian CMP-sialic acid transporter. J. Biol. Chem. 274, 8779-8787.
12. Foulquier, F. (2009). COG defects, birth and rise! Biochim. Biophys. Acta 1792, 896-902.
13. Foulquier, F., Vasile, E., Schollen, E., Callewaert, N., Raemaekers, T., Quelhas, D., Jaeken, J., Mills, P., Winchester, B., Krieger, M. et al. (2006). Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc. Natl. Acad. Sci. USA 103, 3764-3769.
14. Foulquier, F., Ungar, D., Reynders, E., Zeevaert, R., Mills, P., García-Silva, M. T., Briones, P., Winchester, B., Morelle, W., Krieger, M. et al. (2007). A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. Hum. Mol. Genet. 16, 717-730.
15. Foulquier, F., Amyere, M., Jaeken, J., Zeevaert, R., Schollen, E., Race, V., Bammens, R., Morelle, W., Rosnoblet, C., Legrand, D. et al. (2012). TMEM165 deficiency causes a congenital disorder of glycosylation. Am. J. Hum. Genet. 91, 15-26.
16. Freeze, H. H. and Ng, B. G. (2011). Golgi glycosylation and human inherited diseases. Cold Spring Harb. Perspect. Biol. 3, a005371.
17. Füllekrug, J., Suganuma, T., Tang, B. L., Hong, W., Storrie, B. and Nilsson, T. (1999). Localization and recycling of gp27 (hp24gamma3): complex formation with other p24 family members. Mol. Biol. Cell 10, 1939-1955.
18. Gill, D. J., Chia, J., Senewiratne, J. and Bard, F. (2010). Regulation of Oglycosylation through Golgi-to-ER relocation of initiation enzymes. J. Cell Biol. 189, 843-858.
19. Gill, D. J., Clausen, H. and Bard, F. (2011). Location, location, location:new insights into O-GalNAc protein glycosylation. Trends Cell Biol. 21, 149-158.
20. Glick, B. S. and Nakano, A. (2009). Membrane traffic within the Golgi apparatus. Annu. Rev. Cell Dev. Biol. 25, 113-132.
21. Guillard, M., Dimopoulou, A., Fischer, B., Morava, E., Lefeber, D. J., Kornak, U. and Wevers, R. A. (2009). Vacuolar H+-ATPase meets glycosylation in patients with cutis laxa. Biochim. Biophys. Acta 1792, 903-914.
22. Hakomori, S. (2002). Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99, 10231-10233.
23. Hakomori, S. I. and Cummings, R. D. (2012). Glycosylation effects on cancer development. Glycoconj. J. 29, 565-566.
24. Hang, H. C. and Bertozzi, C. R. (2005). The chemistry and biology of mucin-type O-linked glycosylation. Bioorg. Med. Chem. 13, 5021-5034.
25. Hirst, J., Borner, G. H., Harbour, M. and Robinson, M. S. (2005). The aftiphilin/p200/gamma-synergin complex. Mol. Biol. Cell 16, 2554-2565.
26. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S. and Kim, Y. S. (1990). Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66, 1960-1966.
27. Ivanova, A. V., Vortmeyer, A., Ivanov, S. V., Nickerson, M. L., Maher, E. R. and Lerman, M. I. (2008). Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours. J. Pathol. 214, 46-57.
28. Kim, D. W., Massey, T., Sacher, M., Pypaert, M. and Ferro-Novick, S. (2001). Sgf1p, a new component of the Sec34p/Sec35p complex. Traffic 2, 820-830.
29. Kirschmann, D. A., Seftor, E. A., Nieva, D. R., Mariano, E. A. and Hendrix, M. J. (1999). Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res. Treat. 55, 125-134.
30. Kjer-Nielsen, L., van Vliet, C., Erlich, R., Toh, B. H. and Gleeson, P. A. (1999). The Golgi-targeting sequence of the peripheral membrane protein p230. J. Cell Sci. 112, 1645-1654.
31. Kranz, C., Ng, B. G., Sun, L., Sharma, V., Eklund, E. A., Miura, Y., Ungar, D., Lupashin, V., Winkel, R. D., Cipollo, J. F. et al. (2007). COG8 deficiency causes new congenital disorder of glycosylation type IIh. Hum. Mol. Genet. 16, 731-741.
32. Kudlyk, T., Willett, R., Pokrovskaya, I. D. and Lupashin, V. (2013). COG6 interacts with a subset of the Golgi SNAREs and is important for the Golgi complex integrity. Traffic 14, 194-204.
33. Laufman, O., Kedan, A., Hong, W. and Lev, S. (2009). Direct interaction between the COG complex and the SM protein, Sly1, is required for Golgi SNARE pairing. EMBO J. 28, 2006-2017.
34. Laufman, O., Hong, W. and Lev, S. (2011). The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport. J. Cell Biol. 194, 459-472.
35. Laufman, O., Hong, W. and Lev, S. (2013). The COG complex interacts with multiple Golgi SNAREs and enhances fusogenic assembly of SNARE complexes. J. Cell Sci. 126, 1506-1516.
36. Lees, J. A., Yip, C. K., Walz, T. and Hughson, F. M. (2010). Molecular organization of the COG vesicle tethering complex. Nat. Struct. Mol. Biol. 17, 1292-1297.
37. Ley, K. and Kansas, G. S. (2004). Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4, 325-336.
38. Lieu, Z. Z. and Gleeson, P. A. (2011). Endosome-to-Golgi transport pathways in physiological processes. Histol. Histopathol. 26, 395-408.
39. Loh, E. and Hong, W. (2004). The binary interacting network of the conserved oligomeric Golgi tethering complex. J. Biol. Chem. 279, 24640-24648.
40. Lotan, R., Skutelsky, E., Danon, D. and Sharon, N. (1975). The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J. Biol. Chem. 250, 8518-8523.
41. Lu, L., Tai, G. and Hong, W. (2004). Autoantigen Golgin-97, an effector of Arl1 GTPase, participates in traffic from the endosome to the trans-golgi network. Mol. Biol. Cell 15, 4426-4443.
42. Maupin, K. A., Liden, D. and Haab, B. B. (2012). The fine specificity of mannosebinding and galactose-binding lectins revealed using outlier motif analysis of glycan array data. Glycobiology 22, 160-169.
43. Miller, V. J. and Ungar, D. (2012). Re'COG'nition at the Golgi. Traffic 13, 891-897.
44. Molin, K., Fredman, P. and Svennerholm, L. (1986). Binding specificities of the lectins PNA, WGA and UEA I to polyvinylchloride-adsorbed glycosphingolipids. FEBS Lett. 205, 51-55.
45. Nagata, Y. and Burger, M. M. (1974). Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. J. Biol. Chem. 249, 3116-3122.
46. Nakamori, T., Morimoto, A., Yamaguchi, K., Watanabe, T., Long, N. C. and Murakami, N. (1993). Organum vasculosum laminae terminalis (OVLT) is a brain site to produce interleukin-1 beta during fever. Brain Res. 618, 155-159.
47. Nakamura, N., Rabouille, C., Watson, R., Nilsson, T., Hui, N., Slusarewicz, P., Kreis, T. E. and Warren, G. (1995). Characterization of a cis-Golgi matrix protein, GM130. J. Cell Biol. 131, 1715-1726.
48. Ng, B. G., Sharma, V., Sun, L., Loh, E., Hong, W., Tay, S. K. and Freeze, H. H. (2011). Identification of the first COG-CDG patient of Indian origin. Mol. Genet. Metab. 102, 364-367.
49. Ogata, S., Koganty, R., Reddish, M., Longenecker, B. M., Chen, A., Perez, C. and Itzkowitz, S. H. (1998). Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj. J. 15, 29-35.
50. Oka, T., Ungar, D., Hughson, F. M. and Krieger, M. (2004). The COG and COPI complexes interact to control the abundance of GEARs, a subset of Golgi integral membrane proteins. Mol. Biol. Cell 15, 2423-2435.
51. Ono, M. and Hakomori, S. (2004). Glycosylation defining cancer cell motility and invasiveness. Glycoconj. J. 20, 71-78.
52. Paciotti, G. F. and Tamarkin, L. (1988). Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo. Anticancer Res. 8, 1233-1239.
53. Ponnambalam, S., Girotti, M., Yaspo, M. L., Owen, C. E., Perry, A. C., Suganuma, T., Nilsson, T., Fried, M., Banting, G. and Warren, G. (1996). Primate homologues of rat TGN38: primary structure, expression and functional implications. J. Cell Sci. 109, 675-685.
54. Prescott, A. R., Lucocq, J. M., James, J., Lister, J. M. and Ponnambalam, S. (1997). Distinct compartmental ization of TGN46 and beta 1,4-galactosyltransferase in HeLa cells. Eur. J. Cell Biol. 72, 238-246.
55. Rabouille, C., Hui, N., Hunte, F., Kieckbusch, R., Berger, E. G., Warren, G. and Nilsson, T. (1995). Mapping the distribution of Golgi enzymes involved in the construction of complex oligosaccharides. J. Cell Sci. 108, 1617-1627.
56. Rambaruth, N. D., Greenwell, P. and Dwek, M. V. (2012). The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology 22, 839-848.
57. Reynders, E., Foulquier, F., Annaert, W. and Matthijs, G. (2011). How Golgi glycosylation meets and needs trafficking: the case of the COG complex. Glycobiology 21, 853-863.
58. Richardson, B. C., Smith, R. D., Ungar, D., Nakamura, A., Jeffrey, P. D., Lupashin, V. V. and Hughson, F. M. (2009). Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene. Proc. Natl. Acad. Sci. USA 106, 13329-13334.
59. Rosnoblet, C., Legrand, D., Demaegd, D., Hacine-Gherbi, H., de Bettignies, G., Bammens, R., Borrego, C., Duvet, S., Morsomme, P., Matthijs, G. et al. (2013a). Impact of disease-causing mutations on TMEM165 subcellular localization, a recently identified protein involved in CDG-II. Hum. Mol. Genet. 22, 2914-2928.
60. Rosnoblet, C., Peanne, R., Legrand, D. and Foulquier, F. (2013b). Glycosylation disorders of membrane trafficking. Glycoconj. J. 30, 23-31.
61. Schaub, B. E., Berger, B., Berger, E. G. and Rohrer, J. (2006). Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated. Mol. Biol. Cell 17, 5153-5162.
62. Seaman, M. N. (2004). Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J. Cell Biol. 165, 111-122.
63. Seaman, M. N. (2008). Endosome protein sorting: motifs and machinery. Cell. Mol. Life Sci. 65, 2842-2858.
64. Seaman, M. N. (2009). Enhanced SnapShot: endosome-to-golgi retrieval. Cell 139, 1198-1198.e1.
65. Sharon, N. (1983). Lectin receptors as lymphocyte surface markers. Adv. Immunol. 34, 213-298.
66. Sheikh, K. A., Deerinck, T. J., Ellisman, M. H. and Griffin, J. W. (1999). The distribution of ganglioside-like moieties in peripheral nerves. Brain 122, 449-460.
67. Sheldon, P. S., Keen, J. N. and Bowles, D. J. (1998). Purification and characterization of N-glycanase, a concanavalin A binding protein from jackbean (Canavalia ensiformis). Biochem. J. 330, 13-20.
68. Smith, R. D. and Lupashin, V. V. (2008). Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation. Carbohydr. Res. 343, 2024-2031.
69. Spaapen, L. J., Bakker, J. A., van der Meer, S. B., Sijstermans, H. J., Steet, R. A., Wevers, R. A. and Jaeken, J. (2005). Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and Nglycosylation disorder. J. Inherit. Metab. Dis. 28, 707-714.
70. Steet, R. and Kornfeld, S. (2006). COG-7-deficient human fibroblasts exhibit altered recycling of golgi proteins. Mol. Biol. Cell 17, 2312-2321.
71. Tang, D. and Wang, Y. (2013). Cell cycle regulation of Golgi membrane dynamics. Trends Cell Biol. 23, 296-304.
72. Tang, B. L., Low, S. H., Hauri, H. P. and Hong, W. (1995). Segregation of ERGIC53 and the mammalian KDEL receptor upon exit from the 15 degrees C compartment. Eur. J. Cell Biol. 68, 398-410.
73. Tarp, M. A. and Clausen, H. (2008). Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim. Biophys. Acta 1780, 546-563.
74. Tian, E. and Ten Hagen, K. G. (2009). Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj. J. 26, 325-334.
75. Townsley, F. M., Wilson, D. W. and Pelham, H. R. (1993). Mutational analysis of the human KDEL receptor: distinct structural requirements for Golgi retention, ligand binding and retrograde transport. EMBO J. 12, 2821-2829.
76. Ungar, D., Oka, T., Krieger, M. and Hughson, F. M. (2006). Retrograde transport on the COG railway. Trends Cell Biol. 16, 113-120.
77. Velasco, F., Velasco, M., Márquez, I. and Velasco, G. (1993). Role of the centromedian thalamic nucleus in the genesis, propagation and arrest of epileptic activity. An electrophysiological study in man. Acta Neurochir. Suppl. (Wien) 58, 201-204.
78. Virtanen, I. (1990). Helix pomatia agglutinin binds specifically to the Golgi apparatus in cultured human fibroblasts and reveals two Golgi apparatusspecific glycoproteins. Histochemistry 94, 397-401.
79. Walter, D. M., Paul, K. S. and Waters, M. G. (1998). Purification and characterization of a novel 13 S hetero-oligomeric protein complex that stimulates in vitro Golgi transport. J. Biol. Chem. 273, 29565-29576.
80. Willett, R., Kudlyk, T., Pokrovskaya, I., Schönherr, R., Ungar, D., Duden, R. and Lupashin, V. (2013). COG complexes form spatial landmarks for distinct SNARE complexes. Nat. Commun. 4, 1553.
81. Wu, X., Steet, R. A., Bohorov, O., Bakker, J., Newell, J., Krieger, M., Spaapen, L., Kornfeld, S. and Freeze, H. H. (2004). Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat. Med. 10, 518-523.
82. Wuestehube, L. J., Duden, R., Eun, A., Hamamoto, S., Korn, P., Ram, R. and Schekman, R. (1996). New mutants of Saccharomyces cerevisiae affected in the transport of proteins from the endoplasmic reticulum to the Golgi complex. Genetics 142, 393-406.
83. Zeevaert, R., Foulquier, F., Jaeken, J. and Matthijs, G. (2008). Deficiencies in subunits of the Conserved Oligomeric Golgi (COG) complex define a novel group of congenital disorders of glycosylation. Mol. Genet. Metab. 93, 15-21.
84. Zeevaert, R., de Zegher, F., Sturiale, L., Garozzo, D., Smet, M., Moens, M., Matthijs, G. and Jaeken, J. (2013). Bone dysplasia as a key feature in three patients with a novel Congenital Disorder of Glycosylation (CDG) Type II due to a deep intronic splice mutation in TMEM165. JIMD Rep. 8, 145-152.
85. Zolov, S. N. and Lupashin, V. V. (2005). Cog3p depletion blocks vesicle-mediated Golgi retrograde trafficking in HeLa cells. J. Cell Biol. 168, 747-759.